{
    "clinical_study": {
        "@rank": "133004", 
        "arm_group": [
            {
                "arm_group_label": "Group E", 
                "arm_group_type": "Experimental", 
                "description": "Etomidate/remifentanil group. Patients in group E will be given etomidate and remifentanil during the operation, the speeds are 10~15 \u03bcg/kg/min and 0.2~0.4 \u03bcg/kg/min, respectively."
            }, 
            {
                "arm_group_label": "Group P", 
                "arm_group_type": "Experimental", 
                "description": "Propofol/remifentanil group. Patients in group P will be given propofol and remifentanil during the operation, the speeds are 50~75 \u03bcg/kg/min and 0.2~0.4 \u03bcg/kg/min, respectively."
            }
        ], 
        "brief_summary": {
            "textblock": "To compare the effect of propofol and etomidate in hysteroscopy on postoperative sedation\n      and cognitive function in elderly patients"
        }, 
        "brief_title": "A Comparison Between Propofol and Etomidate in Hysteroscopy on Effect of Postoperative Sedation and Cognitive Function in Elderly Patients", 
        "completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Hysteroscopy", 
            "Hemodynamics", 
            "Sedation"
        ], 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. Aged between 60 and 80 years\n\n          2. Selective hysteroscopic operation\n\n          3. American Society of Anesthesiology (ASA) Physical Status: \u2160 or \u2161\n\n          4. Signed informed consent form\n\n          5. Expected operation duration is within 60 minutes\n\n        Exclusion Criteria:\n\n          1. Serious cardiac, cerebral, liver, kidney, lung, endocrine disease or sepsis\n\n          2. Long use of hormone or history of adrenal suppression\n\n          3. Allergy to trial drug or other contraindication\n\n          4. History or expected difficult airway\n\n          5. Identified, suspected abuse or long use of narcotic analgesia\n\n          6. Neuromuscular diseases\n\n          7. Mentally unstable or has a mental illness\n\n          8. Dysfunction of communication\n\n          9. Trend of malignant hyperthermia\n\n         10. Pregnant or breast-feeding women\n\n         11. Attended other trial past 30 days;"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "80 Years", 
            "minimum_age": "60 Years"
        }, 
        "enrollment": {
            "#text": "120", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "May 22, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02147678", 
            "org_study_id": "20140522"
        }, 
        "intervention": [
            {
                "arm_group_label": "Group E", 
                "intervention_name": "Etomidate", 
                "intervention_type": "Drug", 
                "other_name": "Fu Er Li"
            }, 
            {
                "arm_group_label": "Group P", 
                "intervention_name": "Propofol", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Group E", 
                    "Group P"
                ], 
                "description": "During anesthesia maintenance, all patients will be given remifentanil at the speed of 0.2~0.4 \u03bcg/kg/min.", 
                "intervention_name": "Remifentanil", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": [
                    "Group E", 
                    "Group P"
                ], 
                "description": "For all patients, the induction protocol is midazolam 0.1 mg/kg, sufentanil 0.3 \u03bcg/kg, cisatracurium 0.15 mg/kg.", 
                "intervention_name": "Anesthesia induction", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anesthetics", 
                "Etomidate", 
                "Propofol", 
                "Remifentanil"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "May 27, 2014", 
        "number_of_arms": "2", 
        "overall_contact": {
            "email": "swysong2010@126.com", 
            "last_name": "Wenying Song", 
            "phone": "+86-13609245447"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "China: Food and Drug Administration", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "February 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "heart rate will be recorded immediately after the entrance to the operating room, at the beginning of induction, 2.5 min, 5 min, 7.5 min, 10 min, 15 min, 20 min, 25 min and 30 min after the beginning of induction, 5 min, 10 min, 15 min, 20 min, 30 min, 45 min and 60 min after the operation.", 
                "measure": "Heart rate", 
                "safety_issue": "Yes", 
                "time_frame": "Immediately after the entrance to the operating room until until 60 minutes after the operation"
            }, 
            {
                "description": "Mean arterial pressure will be recorded immediately after the entrance to the operating room, at the beginning of induction, 2.5 min, 5 min, 7.5 min, 10 min, 15 min, 20 min, 25 min and 30 min after the beginning of induction, 5 min, 10 min, 15 min, 20 min, 30 min, 45 min and 60 min after the operation.", 
                "measure": "Mean arterial pressure", 
                "safety_issue": "Yes", 
                "time_frame": "Immediately after the entrance to the operating room until until 60 minutes after the operation"
            }, 
            {
                "description": "Pulse oxygen saturation will be recorded immediately after the entrance to the operating room, at the beginning of induction, 2.5 min, 5 min, 7.5 min, 10 min, 15 min, 20 min, 25 min and 30 min after the beginning of induction, 5 min, 10 min, 15 min, 20 min, 30 min, 45 min and 60 min after the operation.", 
                "measure": "Pulse oxygen saturation", 
                "safety_issue": "Yes", 
                "time_frame": "Immediately after the entrance to the operating room until until 60 minutes after the operation"
            }, 
            {
                "description": "Respiratory rate will be recorded immediately after the entrance to the operating room, at the beginning of induction, 2.5 min, 5 min, 7.5 min, 10 min, 15 min, 20 min, 25 min and 30 min after the beginning of induction, 5 min, 10 min, 15 min, 20 min, 30 min, 45 min and 60 min after the operation.", 
                "measure": "Respiratory rate", 
                "safety_issue": "Yes", 
                "time_frame": "Immediately after the entrance to the operating room until until 60 minutes after the operation"
            }, 
            {
                "description": "Narcotrend index will be recorded immediately after the entance to the operating room, at the beginning of induction, 2.5 min, 5 min, 7.5 min, 10 min, 15 min, 20 min, 25 min and 30 min after the beginning of induction, 5 min, 10 min, 15 min, 20 min, 30 min, 45 min and 60 min after the operation.", 
                "measure": "Narcotrend index", 
                "safety_issue": "Yes", 
                "time_frame": "Immediately after the entrance to the operating room until until 60 minutes after the operation"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02147678"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Shaanxi Provincial People's Hospital", 
            "investigator_full_name": "Wenying Song", 
            "investigator_title": "Anesthesiologist", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "2 ml blood will be collected immediately after the entrance to the operating room and 60 min after the operation, then SB-100 protein and neuron-specific enolase will be tested by enzyme-linked immunosorbent assay.", 
                "measure": "Cerebral injury parameters", 
                "safety_issue": "Yes", 
                "time_frame": "Immediately after the entrance to the operating room until until 60 minutes after the operation"
            }, 
            {
                "measure": "Length of stay", 
                "safety_issue": "No", 
                "time_frame": "from the date of admission to the day of discharge, expected to 3 days"
            }, 
            {
                "description": "Score of Minimum Mental State Examination will be examined in preoperative visit, 10 minutes, 45 minutes after the operation", 
                "measure": "Score of Minimum Mental State Examination", 
                "safety_issue": "No", 
                "time_frame": "1 day before the operation to 45 minutes after the operation"
            }, 
            {
                "description": "Verbal Fluency test will be examined in preoperative visit and 60 minutes after the operation", 
                "measure": "Verbal Fluency test", 
                "safety_issue": "No", 
                "time_frame": "1 day before the operation to 60 minutes after the operation"
            }
        ], 
        "source": "Shaanxi Provincial People's Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Shaanxi Provincial People's Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}